SYF2P1

Across TCGA pan-cancer cohorts, SYF2P1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated SYF2P1 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher SYF2P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SYF2P1 expression acts as an unfavorable survival marker.

DLBC, LUSC, and PAAD are the cancer types where SYF2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
LUSC	DFS	Tertile	III,IV	0.205	0.654	.001	36	view →
PAAD	DFS	Tertile	All	0.222	0.486	.037	18	view →
ESCA	DFS	Tertile	II,III,IV	0.328	0.531	.013	18	view →
LGG	DFS	Tertile	All	0.234	0.756	.003	9	view →
LIHC	OS	Tertile	III,IV	0.118	0.615	.003	9	view →
STAD	DFS	Quartile	IV	0.148	0.441	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

SYF2P1–DLBC (OS)

Open the DLBC breakdown →